BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28203337)

  • 1. Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial.
    Mussavi M; Mirnia K; Asadollahi K
    Iran J Pediatr; 2016 Oct; 26(5):e5743. PubMed ID: 28203337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates.
    Sabzevari F; Eslamian M; Karami Robati F; Bahmanbijari B; Daei Parizi Z; Jamali Z
    BMC Pediatr; 2023 Dec; 23(1):608. PubMed ID: 38036980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial.
    Najafian B; Karimi-Sari H; Khosravi MH; Nikjoo N; Amin S; Shohrati M
    Contemp Clin Trials Commun; 2016 Aug; 3():55-59. PubMed ID: 29736457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison efficacy of Curosurf and Survanta in preterm infants with respiratory distress syndrome.
    Mirzarahimi M; Barak M
    Pak J Pharm Sci; 2018 Mar; 31(2):469-472. PubMed ID: 29618436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.
    Gharehbaghi MM; Ganji S; Mahallei M
    Oman Med J; 2021 Jul; 36(4):e289. PubMed ID: 34447583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
    Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
    Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
    Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
    Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
    Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of natural surfactant on mortality and morbidity in neonates with a birth weight below 1500 grams].
    Stranák Z; Janota J; Miletín J; Simák J
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():38-42. PubMed ID: 11394231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE; Pai MG; Al Khusaiby SM
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
    Network of Northwest Neonatal Professional Collaboration Group
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome.
    Yalaz M; Arslanoglu S; Akisu M; Atik T; Ergun O; Kultursay N
    Klin Padiatr; 2004; 216(4):230-5. PubMed ID: 15284947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.
    Herting E; Gefeller O; Land M; van Sonderen L; Harms K; Robertson B
    Pediatrics; 2000 Nov; 106(5):957-64; discussion 1135. PubMed ID: 11061760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome.
    Hammoud M; Al-Kazmi N; Alshemmiri M; Thalib L; Ranjani VT; Devarajan LV; Elsori H
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):167-75. PubMed ID: 15280142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.